Back to Authors

Hansson, Oskar

Mayo Clinic

Lund University

Citations 1

Provider and patient perspectives on the diagnosis and treatment of Alzheimer's disease: A global perspective from the Global Alzheimer's Leadership Series (GoALS)
Andrieu, Sandrine, Bradshaw, Angela, Carmona, Ralph C., Iwatsubo, Takeshi, Hansson, Oskar, Jr, Clifford R Jack, Jicha, Gregory A, McDade, DO Eric, Mummery, Catherine J, Petersen, Ronald C, Robinson, Shelagh, Schneider, Julie A., Shellcross, Lenny, Smith, Amanda G, Snyder, Heather M. , Tapply, Beth, Teunissen, Charlotte, Flier, Wiesje M. van der, Vellas, Bruno, Williamson, Jeff D. , Wilcock, Donna, Carrillo, Maria C., Amouyel, Philippe , Andrieu, Sandrine , Bradshaw, Angela C. , Dumont, Magali , Grinberg, Lea T. , Iwatsubo, Takeshi , Hansson, Oskar , Jack, Clifford R. , Jicha, Gregory A. , Mahinrad, Simin , McDade, Eric , Mummery, Catherine J. , Petersen, Ronald C. , Schneider, Julie A. , Teunissen, Charlotte E. , Flier, Wiesje M. van der , Vellas, Bruno , Wallon, David , Carrillo, María C.

Alzheimer's & Dementia | June 16, 2026 | Volume: 22 | Issue: 6 | Pages: No page available

10.1002/alz.71536 Get It

Abstract Since 2016, the Alzheimer's Association and the Fondation Alzheimer have hosted Global Alzheimer's Leadership Series (GoALS) global think tanks, with world‐leading experts for innovative discussions to advance Alzheimer's disease (AD) research and care. The second GoALS think tank, held in June 2024 in Paris, focused on the relationship between biological changes and clinical manifestations of AD in the context of the evolving therapeutic landscape. Discussions spanned real‐world experiences of providers, patients, and their families, theoretical considerations, and health system challenges. The lived experience perspective was central to these discussions. The importance of shared decision‐making, clear and transparent communication, and the need for real‐world data to holistically support patients during their experiences were highlighted. This manuscript shares key insights from both the think tank meeting in Paris and a featured research session at the 2024 Alzheimer's Association International Conference that expanded the discussion themes for broader dissemination with the community.